Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation

Abstract

Self-assembled drug delivery systems (sDDSs), made from nanocarriers and drugs, are one of the major types of nanomedicines, many of which are in clinical use, under preclinical investigation, or in clinical trials. One of the hurdles of this type of nanomedicine in real applications is the inherent complexity of their fabrication processes, which generally lack precise control over the sDDS structures and the batch-to-batch reproducibility. Furthermore, the classic 2D in vitro cell model, monolayer cell culture, has been used to evaluate sDDSs. However, 2D cell culture cannot adequately replicate in vivo tissue-level structures and their highly complex dynamic 3D environments, nor can it simulate their functions. Thus, evaluations using 2D cell culture often cannot correctly correlate with sDDS behaviors and effects in humans. Microfluidic technology offers novel solutions to overcome these problems and facilitates studying the structure-performance relationships for sDDS developments. In this Review, recent advances in microfluidics for 1) fabrication of sDDSs with well-defined physicochemical properties, such as size, shape, rigidity, and drug-loading efficiency, and 2) fabrication of 3D-cell cultures as "tissue/organ-on-a-chip" platforms for evaluations of sDDS biological performance are in focus.

Prospects and Opportunities for Microsystems and Microfluidic Devices in the Field of Otorhinolaryngology

“…Microfluidic culture of patient-derived tumor tissue has the potential to more closely regenerate the tumor microenvironment [87]. By continually delivering nutrients and removing waste from tissues while maintaining complex multicellular structures without rodent factors, microfluidic technology offers unique properties that could make it a platform for preclinical biological investigations [88]. In previous microfluidic irradiation models with metastatic lymph nodes and primary tumors from different patients, immunohistochemistry expression profiles relevant to cell death and proliferation markers were measured to determine an individual's tumor response to irradiation.…”

Continuous flow fabrication of Fmoc-cysteine based nanobowl infused core–shell like microstructures for pH switchable on-demand anti-cancer drug delivery

“…29 A microfluidic based platform can act as a powerful tool to fabricate self-assembled structures with essential features by keenly manipulating the minute details of their structure-performance relationships. 30 When using microfluidic based synthesis, particle size can be conveniently tuned by altering the flow parameters in the microfluidic channel. Furthermore, it enforces a precise control over the particle's morphological properties owing to the fast diffusion and enhanced heat and mass transfer mechanism achieved in a microchannel environment.…”

Application of microfluidic chips in anticancer drug screening

“…It can simulate tumor microenvironments and construct bionic laboratories of microfluidics. [11,12] In general, a microfluidic chip consists of micro-channels carved on substrate materials such as glass, quartz, or organic plastics silicon, which have an excellent performance. Elastic polydimethylsiloxane (PDMS), acting as the novel material for microfluidic chips, displays more advantages.…”